| Clinical Trials of Quadrivalent Influenza Vaccine (NCT06824519) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2025-05-08 |
| BCG for Therapeutic Use Phase Ⅲ Clinical Trial (NCT06747455) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2025-04-08 |
| Clinical Trial of Protective Efficacy of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris) (NCT06524947) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2024-07-27 |
| BCG for Therapeutic Use Phase I Clinical Trial (NCT06100653) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2023-11-22 |
| Clinical Study of Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells) (NCT06025812) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2023-09-20 |
| Omicron BA.4/5-Delta COVID-19 Vaccine Phase I Clinical Trial (NCT06043388) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2023-09-01 |
| Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above (NCT05899179) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2023-08-03 |
| Phase II Clinical Clical of the Pure Protein Derivatives of BCG (NCT06975774) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2023-07-26 |
| Clinical Trial of Mica (NCT05680415) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2023-04-19 |
| Phase IV Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein (NCT05746611) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2023-04-17 |
| Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells) (NCT05850507) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2023-03-17 |
| Phase Ⅲ Clinical Study of Quadrivalent Influenza Virus Split Vaccine (NCT05642078) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2023-02-18 |
| A Trial Evaluate the Immunogenicity and Safety of Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell) (NCT05616754) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2022-11-07 |
| Recombinant Omicron-Delta COVID-19 Vaccine (CHO Cell) (NCT05574985) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2022-08-29 |
| To Evaluate the Immunogenicity and Safety of Sequential Booster Immunization of Recombinant Novel Coronavirus Vaccine (CHO Cells) for SARS-CoV-2 (NCT05895110) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2022-04-29 |
| Safety Study of COVID19 Vaccine on the Market (NCT05890521) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2022-04-02 |
| A Phase Ⅱ Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02) (NCT05284812) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2022-02-10 |
| ZF2001 Booster Immunization Clinical Trials of 6 Months After the Completion of Basic Immunization (NCT05198063) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2022-01-10 |
| ZF2001 Booster Immunization Clinical Trials of 12 Months After the Completion of Basic Immunization (NCT05198102) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2021-12-29 |
| Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of BBIBP-CorV (NCT05205083) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2021-11-10 |
| Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac (NCT05205096) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2021-11-10 |
| Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus（COVID-19） Vaccine (CHO Cell) (NCT05109598) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2021-11-04 |
| Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells) (NCT05091411) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2021-09-09 |
| Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine (NCT05107375) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2021-09-03 |
| Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing Immunity (NCT05089045) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2021-08-31 |
| Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2（COVID-19） Phase I Clinical Trial (3~17 Years Old) (NCT04961359) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2021-07-03 |
| Phase I Clinical Protocol for Pre-evaluation of the Safety of BCG-PPD in Tuberculosis Patients (NCT04538911) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2021-07-02 |
| A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells) (NCT04852068) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2021-04-10 |
| A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19 (NCT04646590) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2020-12-16 |
| Clinical Study of BCG Vaccine for Intradermal Injection (NCT04563273) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2020-10-21 |
| Phase I Clinical Protocol of BCG-PPD in Healthy People (NCT04593771) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2020-10-21 |
| Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old) (NCT04550351) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2020-08-19 |
| Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris) (NCT04563533) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2020-08-05 |
| Clinical Study of Recombinant Novel Coronavirus Vaccine (NCT04466085) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2020-07-12 |
| Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine (NCT04445194) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2020-06-22 |
| A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02) (NCT04239313) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2020-05-27 |
| A Clinical Trial of Freeze-dried Human Rabies Vaccine (MRC-5 Cells) (NCT06078423) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2019-10-19 |
| A Phase ⅠStudy of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (NCT03026972) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2018-04-16 |